Skip to main content

Table 2 The correlation between SOD, CRP, fibrinogen and the reduced LVEF in diabetic patients with ACS

From: Superoxide dismutases: marker in predicting reduced left ventricular ejection fraction in patients with type 2 diabetes and acute coronary syndrome

Biomakers

Variate type

No. EF < 45% Q1/Q2/Q3/Q4

No adjusted

 

Model 1

 

Model 2

OR (95% CI)

P-value

 

OR (95% CI)

P-value

 

OR (95% CI)

P-value

SOD

Nomicala

91/44/34/20

0.597 (0.517, 0.691)

<0.001

 

0.586 (0.504, 0.681)

<0.001

 

0.638 (0.493, 0.825)

0.001

 

Continuousb

 

0.534 (0.449, 0.635)

<0.001

 

0.519 (0.433, 0.621)

<0.001

 

0.651(0.482, 0.880)

0.005

CRP

Nomicala

20/45/55/72

1.480 (1.287, 1.701)

<0.001

 

1.462 (1.268, 1.685)

<0.001

 

1.076 (0.846, 1.368)

0.551

 

Continuousb

 

1.261 (1.134, 1.403)

<0.001

 

1.218 (1.088, 1.363)

0.001

 

1.060 (0.836, 1.346)

0.63

Fibrinogen

Nomicala

32/40/54/66

1.319 (1.152, 1.510)

<0.001

 

1.334 (1.162, 1.532)

<0.001

 

1.076 (0.858, 1.349)

0.528

 

Continuousb

 

1.379 (1.211, 1.569)

<0.001

 

1.324 (1.160, 1.512)

<0.001

 

1.082 (0.855, 1.368)

0.512

  1. Data are expressed as ORs (95% CI). No adjusted, simple logistic regression; Model 1, multiple logistic regression adjusted for gender, smoking habits, systolic blood pressure; Model 2, multiple logistic regression, using a forward stepwise procedure to select variables, further adjusted for alanine aminotransferase (ALT), high density lipoprotein cholesterol (HDL-C), fasting blood glucose (FBG), HbA1c, serum creatinine (Cr), serum uric acid (UA), NT-proBNP and hs-cTnT.
  2. a The OR was examined by regarding the lowest quartiles as reference; b The HR was examined by evaluating 1 normalized unit increase